At the Helm
The vision and direction of KPS comes from the top. Take a moment to meet the people at the helm, who ensure that our clients receive the unparalleled results, successful outcomes, and premium experience they deserve.
Click to expand our team bios:
DAVID KELLY - PRESIDENT, FOUNDER & CEO
David has over two decades of executive management experience in clinical development. He’s built clinical teams and managed global trials in a variety of medical specialty areas including oncology, diabetes, cardiovascular, ophthalmology, infectious disease, renal, pain and hormone replacement.
In 2006, he founded Kelly Clinical Consultants, a functional service provider that supplied Clinical Research Associates and Project Management for long-term trials. Clients included many of the world’s leading pharmaceutical and biotechnology companies. Among the many trials under the company’s supervision, they also trained, mentored, and managed a team of Russian CRA’s for a hypercholesterolemia trial, and conducted performance evaluations for 28 independent regional contract CRAs.
In 2010, with the help of a private equity investor, Kelly Clinical Consultants became KPS Life. The headquarters were moved from Philadelphia, PA to New York, NY. The platform of a domestic US functional service provider transitioned to a global focus. Today KPS has operations on six continents and practically every country.
Before founding Kelly Clinical Consultants, David served in numerous senior level positions at major global drug companies. At Novartis Pharmaceuticals, he was a clinical research scientist, project manager and director, responsible for 175 Phase III sites worldwide, as well as 20 clinical research associates in a global long term HTN program.
Prior to that, David was senior lead clinical researcher at Wyeth, in the women’s health therapeutic group. He also served at Amylin Pharmaceuticals with a focus on diabetes and diabetic retinopathy. At SmithKline Beecham and GlaxoSmithKline Pharmaceuticals, he was a regional clinical research associate for the Pulmonary and Diabetes therapeutic unit.
David began his career at the global CRO Covance in 1995 as a clinical research associate monitoring clinical drug trials for developmental phase III and IV for sponsor pharmaceutical companies.
David earned his BA in Biology from Rutgers University and continued with graduate studies in Molecular Biology at Rutgers University. His graduate study work focused on cancer and the enzyme target of topoisomerase. He lives in New Jersey with his wife and three sons.
GEORGE SAWICKI - CHIEF OPERATING OFFICER
He joined KPS in 2014 as Vice President of Business Operations & Alliances accountable for growing the client portfolio within KPS. In 2018, he was appointed to Chief Operating Officer of KPS to expand the operational infrastructure and client base within KPS to support its growth and quality of Services delivered. Prior to joining KPS, George was Global Head of R&D Procurement for Teva Pharmaceuticals and Cephalon, Inc. (prior to Teva’s acquisition of Cephalon in 2011). He provided sourcing and procurement strategies for Teva’s R&D organization on the Branded Products side for all clinical categories. In addition, he was accountable for all Strategic Relationship Management (SRM) execution and oversight with Teva’s 3rd party suppliers across R&D.
George was Director of Contracts at ReSearch Pharmaceutical Services, accountable for all Sponsor contracting and study site negotiations worldwide from 2002-2007. He organized and was accountable for the first centralized outsourcing function within Clinical Research for Pfizer’s Global R&D division in Groton, Connecticut.
George began his career at Covance, Inc., a global CRO, as its Director of Finance.
George earned his B.S. in Marketing and Management from West Chester University. He has spoken at numerous pharmaceutical industry conferences over the years and has been instrumental in driving value and cost savings for the pharmaceutical companies that he has worked for through the strategic use of clinical outsourcing providers.
EMANUEL PICHLAK - CHIEF FINANCIAL OFFICER
Prior to joining KPS, Mr. Pichlak spent over a decade in investment management, with transactional experience making private equity & equity growth investments.
Mr. Pichlak received his MBA from Columbia Business School and a MS in Economics from University of Lodz, where he studied computer science and econometrics.
TINA ALM - DIRECTOR, GLOBAL CLINICAL OPERATIONS
Tina M. Alm, BA, CCRA, CCRC, joined KPS in 2018 and is currently Director, Global Clinical Operations.
In this role, Tina provides leadership to the clinical operations team, is a member of the management team, and serves as point of contact for issue escalation. During her tenure at KPS, Tina has managed and help grow our largest FSP Program at a respected Sponsor.
In her 19 years’ clinical research experience, she has held various roles in Clinical Operations, including study coordinator, site co-owner and manager before moving into pharma as a CRA with Roche/Genentech. Tina had a 10+ year career at Roche/Genentech included the roles of CRA, ClinOps Affiliated System Advisor North America, Global FSP System Advisor Lead, and Vendor Manager – Clinical Outsourcing North America, over the IQVIA FSP. She is dual ACRP certified and fluent in English, Spanish and French.
DOMINICK BAIR - SENIOR DIRECTOR, GLOBAL BUSINESS DEVELOPMENT
While at RPS, Dominick held various positions ranging from recruitment, marketing, new business development and account management. During the past 4 years, through the acquisition of RPS by PRA Health Sciences, Dominick supported the Embedded (Strategic Solutions) model globally, as well as providing clients traditional CRO services. He is extremely customer-service focused, listens to clients to best understand their needs, and offers them options for the best solution to efficiently and effectively run their clinical programs.
Dominick earned his Bachelor’s degree from Wilkes University, and lives in Chester Springs, PA.
CHUCK GROHOSKI - DIRECTOR, BUSINESS INTEGRATION & TALENT MANAGEMENT
Chuck started PowerSource Management Professionals in 2015 as Chief Executive Officer, and XPansce in 2009 as Chief Operating Officer. Prior to XPansce, Chuck spent 6 years at Kopos & Baker, where he held a business development manager position. Today, he is driving KPS Life on the business development, recruitment and retention fronts. He is a results-oriented, top-producing recruitment and business development professional, with proven expertise in building long-term, profitable relationships within the healthcare and life science industries.
Chuck has successfully spearheaded large-scale staffing initiatives for major national and international companies, including CROs, biotechnology firms and pharmaceutical giants. Chuck has a keen ability to partner with hiring managers and key decision-makers to define complex labor strategies, and implement effective staffing programs for both short-term and long-term needs. He offers strong expertise in contract, contingent, retained and executive searches, with the ability to identify passive candidates through networking, cold calling and direct recruiting. Chuck has successfully led searches for both executive and staff-level positions.
Chuck earned his Bachelor’s degree from Gwynedd Mercy College, and is currently living in North Coventry, PA.